Top compounds associated with response to TGFB2


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine gCSI pan-cancer AAC 0.083 0.2
mRNA Bortezomib gCSI pan-cancer AAC 0.076 0.3
mRNA MS-275 gCSI pan-cancer AAC 0.054 0.4
mRNA Irinotecan gCSI pan-cancer AAC -0.027 0.7
mRNA Crizotinib gCSI pan-cancer AAC 0.028 0.7
mRNA PD-0325901 gCSI pan-cancer AAC 0.018 0.8
Download CSV